Establishment and Application of an Artificial Intelligence Diagnosis System for Pancreatic Cancer with a Faster Region-Based Convolutional Neural Network
Pancreatic cancer is one of the most common malignant tumors of the digestive system, known for its rapid progression, early metastasis, high mortality, and poor prognosis. Due to its aggressive nature, pancreatic cancer has been referred to as the “king of cancer.” The incidence of pancreatic cancer has been increasing in recent years, and surgery remains the primary therapeutic strategy. However, the lack of specific clinical manifestations and serological markers often leads to late-stage diagnosis, missing the optimal window for radical surgery. Therefore, early diagnosis and accurate staging are critical to improving the cure rate and prognosis of pancreatic cancer.
The pancreas is a retroperitoneal organ with a deep anatomical position and complex surrounding structures, making diagnosis particularly challenging. Imaging technology, especially computed tomography (CT), has become a cornerstone in the diagnosis, staging, and prognosis of pancreatic cancer. CT offers high spatial and density resolutions, avoiding the overlap of anatomical structures seen in other imaging modalities. Contrast-enhanced helical CT, in particular, has become widely accepted for diagnosing and staging pancreatic cancer. However, conventional diagnosis relies heavily on the experience and expertise of imaging specialists, who manually analyze and label pancreatic masses in a series of images. This process is time-consuming, subjective, and prone to variability, limiting the accuracy and reliability of the results.
The rapid development of computer technology and image processing has opened new possibilities in the medical field, particularly in the application of artificial intelligence (AI) for medical image analysis. AI can automate the tedious process of image analysis, reduce manual intervention, and provide consistent, highly accurate results. Deep learning, a subset of AI, has shown remarkable success in diagnosing various cancers, including lung, skin, prostate, breast, and esophageal cancers, often outperforming experienced physicians in image recognition tasks.
This study aims to develop an AI-based system for the automatic diagnosis of pancreatic cancer using a faster region-based convolutional neural network (Faster R-CNN). The system is designed to process sequential contrast-enhanced CT images, identify pancreatic cancer lesions, and provide accurate diagnoses in a fraction of the time required by human specialists. The study is divided into two main processes: training and verification. During the training phase, a database of 4385 CT images from 238 pancreatic cancer patients was used to train the Faster R-CNN model. The verification phase involved testing the trained model on 1699 CT images from 100 pancreatic cancer patients to evaluate its diagnostic accuracy and efficiency.
The Faster R-CNN architecture consists of three main components: a feature extraction network, a region proposal network (RPN), and a proposal classification and regression network. The feature extraction network, initialized using the VGG16 model pre-trained on ImageNet, generates a convolutional feature map of the CT image. The RPN then generates candidate regions of interest (ROIs) by sliding a 3×3 window over the feature map and predicting the probability of each region containing a tumor. The proposal classification and regression network refines the coordinates of the ROIs and classifies them as either positive or negative for pancreatic cancer.
The training process involved four iterative steps: (1) inputting labeled CT images into the Faster R-CNN network to generate feature maps and adjust RPN parameters; (2) using the proposals generated by the RPN to initialize the classification and regression network; (3) fine-tuning the RPN using the parameters from the classification and regression network; and (4) updating the unique convolutional layers in the classification and regression network. The training was conducted using stochastic gradient descent (SGD) with a momentum of 0.9 and a weight decay of 0.0005. The loss function was minimized through backpropagation, and the network weights were continuously updated to optimize performance.
The study included 338 patients with pancreatic cancer, with 238 patients in the training group and 100 patients in the verification group. The clinical characteristics, including sex, age, tumor location, differentiation grade, and tumor-node-metastasis (TNM) stage, were balanced between the two groups. The mean average precision (mAP) of the Faster R-CNN model during training was 0.7664, indicating a good training effect. In the verification phase, the area under the receiver operating characteristic (ROC) curve was 0.9632, demonstrating the high diagnostic accuracy of the AI system. The system processed each CT image in approximately 0.2 seconds, significantly faster than the time required by imaging specialists.
The AI system’s ability to accurately diagnose pancreatic cancer was further validated by comparing its results with those of imaging specialists. The system achieved a high sensitivity, specificity, and accuracy, making it a valuable tool for assisting radiologists in providing more precise diagnoses. The study also highlighted the potential of AI to reduce the workload of imaging specialists, improve diagnostic consistency, and enhance patient outcomes.
Despite its promising results, the study has some limitations. It is a retrospective analysis based on data from a single center, and the verification group included only patients with pancreatic cancer, excluding those with benign pancreatic lesions or normal pancreatic tissue. Future research should focus on prospective, multicenter studies to further validate the clinical application of the AI system. Additionally, the training and testing groups should be reorganized to include a broader range of pancreatic conditions to improve the system’s diagnostic versatility.
In conclusion, this study successfully established an AI-based diagnostic system for pancreatic cancer using the Faster R-CNN deep neural network. The system demonstrated high accuracy, efficiency, and clinical feasibility, making it a valuable tool for assisting imaging specialists in the early diagnosis and staging of pancreatic cancer. The integration of AI into medical imaging has the potential to revolutionize the field of oncology, providing faster, more accurate, and more objective diagnoses that can improve patient outcomes and reduce the burden on healthcare professionals.
doi.org/10.1097/CM9.0000000000000544
Was this helpful?
0 / 0